September 27- EOD

Not a particularly news rich day but the sector seemed to continue its momentum from yesterday and seemed to outperform the general market with a lot of green on a.

September 26-EOD

It was an interesting news day and biotechs even participated in the market strength today, which has not happened in a little while. I would not call the biotech action.

September 25- EOD

A very interesting and odd day in the market today. Overall the market continued its weakness and biotechs were generally down. The market came back and it seemed to turn.

September 24- EOD

Not a lot going on today, which works out well as it has been a busy day for me outside of biotech. The market seemed to find its footing a.

September 24- EOD

Not a lot going on today, which works out well as it has been a busy day for me outside of biotech. The market seemed to find its footing a.

September 24- EOD

Not a lot going on today, which works out well as it has been a busy day for me outside of biotech. The market seemed to find its footing a.

September 23rd EOD

It was a weak day in biotech (although it seemed to recover a little in the afternoon) and some of the biggest biotech bulls are turning cautious. Mike King of.

September 20- Daily Update – SRPT

Obviously the big news of the day was the failure of drisapersen in their phase III trial and what it means for etperlirsen and SRPT. While it is not clear.

September 19- EOD

It was a relatively quiet news day. I was not sure there would be much to write about and there is nothing really new or compelling. There are some quick.

September 18- EOD

It was Fed day today, so the market was very macro driven in terms of price action. The Bernank doubled down on easing, which was a good macro environment. That.

September 18- EOD

It was Fed day today, so the market was very macro driven in terms of price action. The Bernank doubled down on easing, which was a good macro environment. That.

September 18- EOD

It was Fed day today, so the market was very macro driven in terms of price action. The Bernank doubled down on easing, which was a good macro environment. That.

September 17- EOD

Not a lot of stock specific news but some interesting larger biotech developments. The market held up better than I thought given yesterday’s close and biotechs seemed like slight underperformers.

September 16- EOD

It was a strong day in the market but a weak day in biotech. That being said I think there was a definite pattern in that the large caps and.

September 16- EOD

It was a strong day in the market but a weak day in biotech. That being said I think there was a definite pattern in that the large caps and.

September 16- EOD

It was a strong day in the market but a weak day in biotech. That being said I think there was a definite pattern in that the large caps and.

September 13- EOD

Generally a mixed day in biotech land today with some interesting stock specific moves but nothing really dramatic in terms of news. Looks like a quiet end to the week.

September 12- EOD

Another relatively weak day in biotech land but this is not to say that the market in general was particularly strong. It is not surprising that both the market and.

September 12- EOD

Another relatively weak day in biotech land but this is not to say that the market in general was particularly strong. It is not surprising that both the market and.

September 12- EOD

Another relatively weak day in biotech land but this is not to say that the market in general was particularly strong. It is not surprising that both the market and.

Browsing 20 / articles